-15 -14 -13 -12 -11 -10 -09 -08 -07 -06 -05 -04 -03 -02 -01 | page 01 of 02 |
+01 +02 +03 +04 +05 +06 +07 +08 +09 +10 +11 +12 +13 +14 +15 | <- Back | Next page -> |
0_README.html | ||
Allele_origin.txt | ||
Analyte_category.txt | ||
CAP_test_categories.txt | ||
CAP_test_codes.txt | ||
CAP_test_list.txt | ||
Clinical_significance.txt | ||
Clinical_utility_categories.txt | ||
Contact_policy.txt | ||
Disease_mechanism.txt | ||
External_programs.txt | ||
FDA_Category_Pt_1.txt | ||
FDA_Category_Pt_2.txt | ||
FDA_status.txt | ||
Gender.txt | ||
Instruments.txt | ||
Items_FDA_reviewed.txt | ||
Laboratory_services.txt | ||
Major_method_category.txt | ||
Method_category.txt | ||
Mode_of_inheritance.txt | ||
Molecular_consequence.txt | ||
NYS_CLEP_status.txt | ||
Pathogenicity_properties_(LOVD).txt | ||
Person_database_permissions.txt | ||
Personnel_titles.txt | ||
Platform_type.txt | ||
Platforms.txt | ||
Primary_test_methodology.txt | ||
Proficiency_testing_method.txt |
-15 -14 -13 -12 -11 -10 -09 -08 -07 -06 -05 -04 -03 -02 -01 | page 01 of 02 |
+01 +02 +03 +04 +05 +06 +07 +08 +09 +10 +11 +12 +13 +14 +15 | <- Back | Next page -> |